Amylyx Pharmaceuticals, Inc. financial data

Symbol
AMLX on Nasdaq
Industry
Pharmaceutical Preparations
Location
43 Thorndike Street, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 613 % -16.5%
Quick Ratio 44.6 %
Debt-to-equity 18.7 % +9.54%
Return On Equity -18.2 % +68.5%
Return On Assets -15.3 % +69%
Operating Margin -20.4 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68M shares +1.93%
Common Stock, Shares, Outstanding 68M shares +1.31%
Entity Public Float 1.31B USD +66.2%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 67.9M shares +1.7%
Weighted Average Number of Shares Outstanding, Diluted 67.9M shares -4.25%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 22.2M USD +7700%
Revenue from Contract with Customer, Excluding Assessed Tax 398M USD +24.1%
Research and Development Expense 141M USD +46.2%
General and Administrative Expense 30M USD +292%
Costs and Expenses 479M USD +92.3%
Operating Income (Loss) -81.3M USD +47.8%
Nonoperating Income (Expense) 15.6M USD +120%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -65.7M USD +55.8%
Income Tax Expense (Benefit) 5.44M USD +1087%
Net Income (Loss) Attributable to Parent -71.1M USD +52.3%
Earnings Per Share, Basic -1.04 USD/shares +57.4%
Earnings Per Share, Diluted -1.07 USD/shares +56.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 171M USD +48.9%
Accounts Receivable, after Allowance for Credit Loss, Current 20.4M USD +15.9%
Inventory, Net 38.3M USD +292%
Assets, Current 411M USD +5.52%
Property, Plant and Equipment, Net 2.46M USD -3.91%
Operating Lease, Right-of-Use Asset 3.25M USD -36.1%
Other Assets, Noncurrent 493K USD +5.79%
Assets 417M USD +2.33%
Accounts Payable, Current 21.5M USD +99.2%
Employee-related Liabilities, Current 15.2M USD +256%
Accrued Liabilities, Current 67.9M USD +75.1%
Liabilities, Current 91.6M USD +77.5%
Operating Lease, Liability, Noncurrent 1.38M USD -62.6%
Liabilities 93M USD +68.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -77K USD -408%
Retained Earnings (Accumulated Deficit) -424M USD -20.2%
Stockholders' Equity Attributable to Parent 324M USD -8%
Liabilities and Equity 417M USD +2.33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -489K USD +90.4%
Net Cash Provided by (Used in) Financing Activities 131K USD -87.4%
Net Cash Provided by (Used in) Investing Activities 819K USD -98.5%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 68M shares +1.31%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 351K USD -99.3%
Deferred Tax Assets, Valuation Allowance 83.9M USD -7.36%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 85.5M USD -7.06%
Operating Lease, Liability 4.24M USD -32.5%
Depreciation 315K USD +54.4%
Payments to Acquire Property, Plant, and Equipment 67K USD -73.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -71.2M USD +52.1%
Lessee, Operating Lease, Liability, to be Paid 4.54M USD -34.7%
Property, Plant and Equipment, Gross 4.31M USD +36.9%
Operating Lease, Liability, Current 2.31M USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.59M USD -36%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.48M USD +2.52%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 303K USD -55.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 476K USD -70%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 5.25M USD +578%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.21M USD +118%
Lessee, Operating Lease, Liability, to be Paid, Year Four 476K USD
Operating Lease, Payments 2.4M USD +71.4%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 2.84M USD
Current Federal Tax Expense (Benefit) 1.22M USD
Deferred Tax Assets, Net of Valuation Allowance 1.55M USD +12.5%
Share-based Payment Arrangement, Expense 39.6M USD +59.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%